AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 191 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $28,236,000 | +24.7% | 3,003,875 | +1.5% | 1.55% | +14.1% |
| Q2 2020 | $22,641,000 | +22.0% | 2,959,587 | -1.4% | 1.36% | -12.5% |
| Q1 2020 | $18,557,000 | -49.9% | 3,002,748 | -1.4% | 1.55% | -23.8% |
| Q4 2019 | $37,050,000 | +4.2% | 3,044,374 | -1.1% | 2.04% | -13.9% |
| Q3 2019 | $35,561,000 | +5.5% | 3,078,874 | -8.8% | 2.37% | +44.5% |
| Q2 2019 | $33,721,000 | -23.5% | 3,375,506 | -1.3% | 1.64% | -10.8% |
| Q1 2019 | $44,066,000 | -14.2% | 3,421,306 | +1.2% | 1.84% | -32.8% |
| Q4 2018 | $51,350,000 | -24.0% | 3,380,506 | 0.0% | 2.73% | +0.0% |
| Q3 2018 | $67,610,000 | +3.8% | 3,380,506 | +1.2% | 2.73% | +5.0% |
| Q2 2018 | $65,146,000 | -3.2% | 3,340,806 | 0.0% | 2.60% | -9.6% |
| Q1 2018 | $67,317,000 | +45.4% | 3,340,806 | -4.4% | 2.88% | +44.5% |
| Q4 2017 | $46,285,000 | -27.1% | 3,493,220 | +1.5% | 1.99% | -25.5% |
| Q3 2017 | $63,491,000 | +3.2% | 3,441,233 | +2.9% | 2.67% | -6.9% |
| Q2 2017 | $61,541,000 | -18.4% | 3,344,620 | 0.0% | 2.87% | -19.4% |
| Q1 2017 | $75,421,000 | -35.2% | 3,344,620 | 0.0% | 3.56% | -46.3% |
| Q4 2016 | $116,393,000 | +42.7% | 3,344,620 | +0.5% | 6.64% | +40.2% |
| Q3 2016 | $81,538,000 | +4.1% | 3,326,720 | +1.6% | 4.74% | -19.9% |
| Q2 2016 | $78,295,000 | +15.1% | 3,273,220 | +12.6% | 5.91% | +12.0% |
| Q1 2016 | $68,005,000 | -20.6% | 2,906,194 | +2.5% | 5.28% | +10.8% |
| Q4 2015 | $85,613,000 | -22.4% | 2,835,792 | +2.1% | 4.76% | -10.2% |
| Q3 2015 | $110,346,000 | -27.1% | 2,777,392 | +26.7% | 5.31% | -21.2% |
| Q2 2015 | $151,389,000 | +26.6% | 2,192,141 | +0.2% | 6.73% | +13.9% |
| Q1 2015 | $119,544,000 | +40.7% | 2,187,041 | +9.7% | 5.91% | +18.5% |
| Q4 2014 | $84,993,000 | +65.0% | 1,994,200 | +23.5% | 4.99% | +29.6% |
| Q3 2014 | $51,520,000 | +54.0% | 1,614,536 | 0.0% | 3.85% | +54.5% |
| Q2 2014 | $33,453,000 | -46.5% | 1,614,536 | -50.0% | 2.49% | -3.6% |
| Q1 2014 | $62,482,000 | +46.1% | 3,229,072 | +83.3% | 2.58% | -35.2% |
| Q4 2013 | $42,765,000 | +16.1% | 1,761,332 | +2.7% | 3.99% | +3.3% |
| Q3 2013 | $36,836,000 | -1.5% | 1,715,377 | +2.1% | 3.86% | -12.5% |
| Q2 2013 | $37,399,000 | – | 1,680,871 | – | 4.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |